ArticleJournal of the Egyptian National Cancer Institute2024

Utility of clinical, laboratory, and lymph node MYD88 L265P mutation in risk assessment of diffuse large B-cell lymphoma patients.

Ahmed Talaat Hanbal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.